Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
84216 trials found · Page 11 of 4211
-
Could treating school kids stop malaria for everyone?
Prevention Not yet recruitingThe CRITICal study aims to estimate the effectiveness of intermittent preventive treatment in school children (IPTsc) with dihydroartemisinin-piperaquine (DP) for reducing community level malaria burden. Given that school-aged children are the primary drivers of transmission, the…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Apr 20, 2026 16:15 UTC
-
Magic mushroom therapy trial aims to curb severe alcohol addiction
Disease control Not yet recruitingThis study aims to determine the safety and preliminary efficacy of psilocybin-assisted psychotherapy in improving alcohol-related outcomes among adults with severe alcohol use disorder in a a double-blind, dose-comparison concurrent control, randomized trial. Participants will u…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Apr 16, 2026 12:47 UTC
-
Breakthrough trial aims to replace toxic fungal treatment with Single-Dose therapy
Disease control Not yet recruitingLAmB-FAST is a factorial randomized controlled trial simultaneously testing two interventions in one trial. LAmB-FAST seeks to inform treatment guidelines on the induction and maintenance therapy of HIV-associated talaromycosis (formerly called penicilliosis) and will answer the …
Phase: PHASE3 • Sponsor: Duke University • Aim: Disease control
Last updated Apr 15, 2026 16:14 UTC
-
Major trial aims to stop psychosis before it starts using CBD
Prevention Not yet recruitingThe purpose of this trial is: * To investigate whether cannabidiol (CBD), compared to placebo, can reduce the severity of attenuated psychotic symptoms in individuals at clinical high risk for psychosis. * To confirm the safety of CBD in individuals at clinical high risk for psy…
Phase: PHASE3 • Sponsor: University of Oxford • Aim: Prevention
Last updated Apr 13, 2026 20:20 UTC
-
Weight-Loss drug tested as potential Game-Changer for alcohol addiction in veterans
Disease control Not yet recruitingThis clinical trial aims to test the effectiveness and safety of semaglutide, a GLP-1 receptor agonist, in treating moderate to severe alcohol use disorder (AUD) in Veterans. Participants who qualify will be randomly assigned to receive either semaglutide injections or placebo in…
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Apr 09, 2026 19:31 UTC
-
New hope for kids battling relapsed neuroblastoma
Disease control Not yet recruitingThis phase I/II trial studies the side effects and best dose of iberdomide when given together with chemoimmunotherapy drugs and to see how well it works in treating patients with neuroblastoma that has come back after a period of improvement (relapsed), that does not respond to …
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 13, 2026 20:16 UTC
-
Race against time: can a procedure help stroke patients who arrive late?
Disease control Recruiting nowSELECT LATE trial aims to evaluate if addition of endovascular thrombectomy to medical management in patients presenting with acute ischemic stroke and a proximal large vessel occlusion in the anterior circulation between 24 and 72 hours of stroke onset results in achieving bette…
Phase: NA • Sponsor: Amrou Sarraj • Aim: Disease control
Last updated Apr 16, 2026 13:01 UTC
-
Race to stop Leukemia's return: two drugs face off in major transplant trial
Disease control Recruiting nowThe study population consisted of FLT3-ITD-mutated AML patients who were FLT3-ITD-positive before allogeneic hematopoietic stem cell transplantation. This open-label, randomized, controlled trial enrolled participants and randomly assigned them in a 1:1 ratio to either the experi…
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Apr 13, 2026 20:23 UTC
-
Old drug, new fight: repurposed medicine targets deadly dengue
Disease control Not yet recruitingThe goal of this study is to evaluate the efficacy and safety of emetine administered orally for symptomatic patients aged 18-65 years infected with the dengue virus. The main questions it aims to answer are: 1. Does emetine reduce 28-day mortality or progression to severe dengu…
Phase: PHASE2, PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Apr 13, 2026 20:19 UTC
-
Heart repair breakthrough: stem cells injected during surgery in major trial
Disease control Recruiting nowThe purpose of this clinical study is to evaluate the efficacy and safety of intramyocardial injection of human induced pluripotent stem cell-derived cardiomyocyte injection (HiCM-188) in patients with advanced heart failure (NYHA Class III-IV)
Phase: PHASE3 • Sponsor: HELP Therapeutics Co., Ltd. • Aim: Disease control
Last updated Apr 16, 2026 13:00 UTC
-
New hope for Tough-to-Treat esophageal cancer: major trial compares experimental drug to standard chemo
Disease control Not yet recruitingThis is a large clinical study carried out at multiple hospitals. Participants will be randomly assigned to one of two groups: one group will receive a new medicine called YL201, and the other group will receive standard chemotherapy chosen by the doctor. The purpose of the stud…
Phase: PHASE3 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC
-
New vaccine combo trial offers hope for kids with devastating brain tumors
Disease control Not yet recruitingThis is a multisite, phase I/II clinical trial in children and young adults with newly-diagnosed high-grade glioma (HGG), diffuse midline glioma (DMG) and recurrent HGG/DMG, Medulloblastoma (MB), or ependymoma (EPN) to determine the safety, immunogenicity, and efficacy of a CMV-d…
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC
-
CAR T-Cells take aim at devastating scleroderma lung scarring in major trial
Disease control Not yet recruitingThe purpose of this study is to compare the efficacy and safety of BMS-986353 versus standard of care in participants with active Systemic Sclerosis
Phase: PHASE3 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New Two-Pronged attack on deadly brain cancer begins human testing
Disease control Not yet recruitingThis is a phase IB/II, open-label study evaluating CTX-009 as monotherapy and in combination with CTX-471. The study evaluates the safety and efficacy of the monotherapy and the combination in patients with recurrent glioblastoma. The study tests the hypothesis that treatment wit…
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 13, 2026 20:18 UTC
-
New hope for blood cancer patients: Three-Drug combo trial aims to outperform standard chemo
Disease control Not yet recruitingThis is a multicenter, randomized, controlled, open-label phase III trial evaluating the efficacy and safety of the VAG regimen (azacitidine, venetoclax, and gilteritinib) compared with standard 3+7 chemotherapy (cytarabine plus daunorubicin or idarubicin) combined with gilteriti…
Phase: PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 20, 2026 16:17 UTC
-
New drug aims to attack breast cancer that spreads to the brain
Disease control Not yet recruitingThe purpose of this study is to assess the efficacy and safety of RO7771950 in combination with trastuzumab and capecitabine, compared to tucatinib in combination with trastuzumab and capecitabine.
Phase: PHASE2, PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 09, 2026 19:33 UTC
-
New hemophilia drug aims to outperform current standard
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of NXT007 prophylaxis compared with emicizumab prophylaxis in people age 12 years and older with severe or moderate congenital hemophilia A without factor VIII (FVIII) inhibitors…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Poop transplant trial aims to reboot cancer treatment
Disease control Not yet recruitingThis study aims to investigate the efficacy and safety of fecal microbiota transplantation (FMT) as a treatment for non-small cell lung cancer (NSCLC) patients whose disease has progressed after immune checkpoint inhibitor (ICI) therapy, and to establish the foundation for person…
Phase: PHASE2 • Sponsor: Se-Hoon Lee • Aim: Disease control
Last updated Apr 15, 2026 16:13 UTC
-
New 'Living Drug' trial offers hope for Tough-to-Treat lymphoma
Disease control Recruiting nowTo evaluate the safety and tolerability of GB5005 in patients with CD19-positive relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL).
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Apr 20, 2026 16:14 UTC
-
New hope for advanced stomach cancer: major trial tests promising drug combo
Disease control Recruiting nowThis study is being done to learn more about a new medicine called PF-08634404 and how well it works when given with chemotherapy to people with gastroesophageal cancer that is locally advanced (spread to nearby tissues) or has spread to other parts of the body. To join the stud…
Phase: PHASE2, PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 20, 2026 16:18 UTC